Kuehne + Nagel opens CGT logistics centre in Chicago
May 21, 2019
Kuehne + Nagel subsidiary Quick has opened a cell and gene therapy (CGT) logistics facility in Chicago to support the life science community.
While healthcare and life science logistics are complex for all types of medical shipments, gene, cell and immunotherapies have special challenges, and the logistics need to be synchronised throughout the supply chain to ensure product integrity, patient safety and successful outcomes.
Cell and gene therapy treatments are different for each patient and require individual handling and precise timing. These new therapies are also high value, extremely time and temperature-sensitive, and require specialised handling, packaging and storage.
Quick's new 2800 square metre CGT centre of excellence is in Chicago, close to Chicago's O'Hare airport. Designed for GDP (good distribution practices) compliance, it has controlled room temperature in-transit storage and is a conditioning and storage facility for Credo units and nitrogen shippers, used for transport of CGT therapies.
Life science logistics specialists will provide clients with round-the-clock customised services from specially designed processes, pre-planning of routings, packaging procurement, conditioning and placement to regulatory compliance and temperature monitoring devices. Quick's technology provides transparency, data integration and real-time information.
"Quick's investment in our new cutting edge CGT facility, recruitment of highly experienced logistics specialists and innovative technology to synchronise the CGT supply chain reflects our commitment to support the life science community," said David Murphy, executive vice president at Quick. “We are proud to partner with pharmaceutical and biotech companies that are developing these exciting new therapies and provide them comprehensive logistics support.”
Quick is a logistics company for the healthcare and life science industry, serving the community for nearly 40 years. Quick, part of Kuehne + Nagel, safely and quickly transports human organs and tissue for transplant or research, blood, blood products, cord blood, bone marrow, medical devices, and equipment, as well as cell and gene therapies.
With almost 82,000 employees at more than 1300 locations in over 100 countries, the Kuehne + Nagel group is a major logistics company. Its strong market position lies in the seafreight, airfreight, contract logistics and overland businesses, with a focus on providing IT-based integrated logistics.